These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 1672836)
1. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall. Vecchiarelli A; Puliti M; Torosantucci A; Cassone A; Bistoni F Cell Immunol; 1991 Apr; 134(1):65-76. PubMed ID: 1672836 [TBL] [Abstract][Full Text] [Related]
2. Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans. Torosantucci A; Palma C; Boccanera M; Ausiello CM; Spagnoli GC; Cassone A J Gen Microbiol; 1990 Nov; 136(11):2155-63. PubMed ID: 1706757 [TBL] [Abstract][Full Text] [Related]
3. A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice. Mencacci A; Torosantucci A; Spaccapelo R; Romani L; Bistoni F; Cassone A Infect Immun; 1994 Dec; 62(12):5353-60. PubMed ID: 7960114 [TBL] [Abstract][Full Text] [Related]
4. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha. Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154 [TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of a monoclonal antibody against mannoprotein of Candida albicans. Farahnejad Z; Rasaee MJ; Moghadam MF; Paknejad M; Kashanian S; Rajabi M Hybridoma (Larchmt); 2005 Jun; 24(3):146-51. PubMed ID: 15943562 [TBL] [Abstract][Full Text] [Related]
6. Antigenic differences in the surface mannoproteins of Candida albicans as revealed by monoclonal antibodies. Sundstrom PM; Tam MR; Nichols EJ; Kenny GE Infect Immun; 1988 Mar; 56(3):601-6. PubMed ID: 3277915 [TBL] [Abstract][Full Text] [Related]
7. Biochemical and antigenic characterization of mannoprotein constituents released from yeast and mycelial forms of Candida albicans. Torosantucci A; Gomez MJ; Bromuro C; Casalinuovo I; Cassone A J Med Vet Mycol; 1991; 29(6):361-72. PubMed ID: 1815028 [TBL] [Abstract][Full Text] [Related]
8. Antigenic cell wall mannoproteins in Candida albicans isolates and in other Candida species. Gil ML; Casanova M; Martínez JP; Sentandreu R J Gen Microbiol; 1991 May; 137(5):1053-61. PubMed ID: 1713949 [TBL] [Abstract][Full Text] [Related]
9. The Candida albicans phospholipomannan induces in vitro production of tumour necrosis factor-alpha from human and murine macrophages. Jouault T; Bernigaud A; Lepage G; Trinel PA; Poulain D Immunology; 1994 Oct; 83(2):268-73. PubMed ID: 7835946 [TBL] [Abstract][Full Text] [Related]
10. Salmonella typhimurium induces IFN-gamma production in murine splenocytes. Role of natural killer cells and macrophages. Ramarathinam L; Niesel DW; Klimpel GR J Immunol; 1993 May; 150(9):3973-81. PubMed ID: 8473744 [TBL] [Abstract][Full Text] [Related]
12. Both viable and killed Candida albicans cells induce in vitro production of TNF-alpha and IFN-gamma in murine cells through a TLR2-dependent signalling. Murciano C; Yáñez A; Gil ML; Gozalbo D Eur Cytokine Netw; 2007 Mar; 18(1):38-43. PubMed ID: 17400537 [TBL] [Abstract][Full Text] [Related]
13. Production of cytokines after lipopolysaccharide stimulation of murine spleen cells during lymphoma development in AKR mice. Vaillier D; Daculsi R; Legrand E; Guillemain B Cancer Immunol Immunother; 1989; 29(1):35-42. PubMed ID: 2468413 [TBL] [Abstract][Full Text] [Related]
14. Responsiveness of human polymorphonuclear cells (PMNL) to stimulation by a mannoprotein fraction (MP-F2) of Candida albicans; enhanced production of IL-6 and tumour necrosis factor-alpha (TNF-alpha) by MP-F2-stimulated PMNL from HIV-infected subjects. Torosantucci A; Chiani P; Quinti I; Ausiello CM; Mezzaroma I; Cassone A Clin Exp Immunol; 1997 Mar; 107(3):451-7. PubMed ID: 9067516 [TBL] [Abstract][Full Text] [Related]
15. Differences in the antigenic expression of immunomodulatory mannoprotein constituents on yeast and mycelial forms of Candida albicans. Torosantucci A; Boccanera M; Casalinuovo I; Pellegrini G; Cassone A J Gen Microbiol; 1990 Jul; 136(7):1421-8. PubMed ID: 1700063 [TBL] [Abstract][Full Text] [Related]
16. Production of IL-6 and TNF-alpha by the macrophage-like cell line RAW 264.7 after treatment with a cell wall extract of Candida albicans. Vazquez N; Buckley HR; Rogers TJ J Interferon Cytokine Res; 1996 Jun; 16(6):465-70. PubMed ID: 8807501 [TBL] [Abstract][Full Text] [Related]
17. Chemical definition of an epitope/adhesin molecule on Candida albicans. Li RK; Cutler JE J Biol Chem; 1993 Aug; 268(24):18293-9. PubMed ID: 7688744 [TBL] [Abstract][Full Text] [Related]
18. Impaired immune response to Candida albicans in aged mice. Murciano C; Villamón E; Yáñez A; O'Connor JE; Gozalbo D; Gil ML J Med Microbiol; 2006 Dec; 55(Pt 12):1649-1656. PubMed ID: 17108267 [TBL] [Abstract][Full Text] [Related]
19. Cell wall mannoprotein of Candida albicans polarizes macrophages and affects proliferation and apoptosis through activation of the Akt signal pathway. Jiang HH; Zhang YJ; Sun YZ; Qi RQ; Chen HD; Gao XH Int Immunopharmacol; 2019 Jul; 72():308-321. PubMed ID: 31005041 [TBL] [Abstract][Full Text] [Related]